Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 1998

View Archived Issues

Dornier's BPH device approved by FDA

Biomira updates shareholders at annual general meeting

Aastrom Biosciences receives SBIR grant for dendritic cell expansion technology research

Argonex raises funds for cancer vaccine programs

Dura and Spiros provide development update on asthma products

Urinary reflux product enters phase III

Genome Therapeutics reaches milestone in Schering-Plough alliance

Initiation of late-stage Avicine clinical trial

Access and Block Drug sign agreement for international rights to amlexanox

Molecules to Market changes name

Sertoli Technologies issued second U.S. patent for Sertoli-based cell therapies

Hemosol advances blood substitute in clinical studies for several indications

Procept's PRO-2000 gel protects against herpes infection in mice

Flavopiridol induces apoptosis, regression of human hematological malignancies

17beta-HSD type 1 inhibitors: a new treatment option for hormone-dependent breast cancer

Abbott and Boehringer Ingelheim sign comarketing agreement

PNU-151774E, a safe and effective anticonvulsant in preclinical testing

Procter & Gamble R&D on metalloprotease inhibition

Perimidine-based CRF antagonists developed at Agouron

BMS prepares novel sulfenamide taxane derivatives

Byk Gulden patents another series of thiazole PDE IV inhibitors

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

Lactadherin protects against symptomatic rotavirus infection in infants

No-approval recommendation given for AD-32 by FDA advisory committee

Large U.S. trial confirms high efficacy rate of mifepristone + misoprostol in early pregnancy

Rebetron now available in the U.S.

U.K. launch of Zoladex for assisted conception

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...